Abstract:The bacterial archetypal adaptive immune system, CRISPR-Cas, is thought to be repressed in the best-studied bacterium, Escherichia coli K-12. We show here that the E. coli CRISPR-Cas system is active and serves to inhibit its nine defective (i.e., cryptic) prophages. Specifically, compared to the wild-type strain, reducing the amounts of specific interfering RNAs (crRNA) decreases growth by 40%, increases cell death by 700%, and prevents persister cell resuscitation. Similar results were obtained by inactivating CRISPR-Cas by deleting the entire 13 spacer region (CRISPR array); hence, CRISPR-Cas serves to inhibit the remaining deleterious effects of these cryptic prophages, most likely through CRISPR array-derived crRNA binding to cryptic prophage mRNA rather than through cleavage of cryptic prophage DNA, i.e., self-targeting. Consistently, four of the 13 E. coli spacers contain complementary regions to the mRNA sequences of seven cryptic prophages, and inactivation of CRISPR-Cas increases the level of mRNA for lysis protein YdfD of cryptic prophage Qin and lysis protein RzoD of cryptic prophage DLP-12. In addition, lysis is clearly seen via transmission electron microscopy when the whole CRISPR-Cas array is deleted, and eliminating spacer #12, which encodes crRNA with complementary regions for DLP-12 (including rzoD), Rac, Qin (including ydfD), and CP4-57 cryptic prophages, also results in growth inhibition and cell lysis. Therefore, we report the novel results that (i) CRISPR-Cas is active in E. coli and (ii) CRISPR-Cas is used to tame cryptic prophages, likely through RNAi, i.e., unlike with active lysogens, active CRISPR-Cas and cryptic prophages may stably co-exist.

Restriction endonuclease cleavage of phage DNA enables resuscitation from Cas13-induced bacterial dormancy

The Cas10 nuclease activity relieves host dormancy to facilitate spacer acquisition and retention during type III-A CRISPR immunity

Phage CRISPR-like regulatory RNAs silence bacterial adaptive and innate immunity

Selective degradation of phage RNAs by the Csm6 ribonuclease provides robust type III CRISPR immunity in Streptococcus thermophilus

tRNA anticodon cleavage by target-activated CRISPR-Cas13a effector

Bacteriophage Cooperation Suppresses CRISPR-Cas3 and Cas9 Immunity

The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA

Diverse viral cas genes antagonize CRISPR immunity

CRISPR-Cas Controls Cryptic Prophages

Bacteriophages suppress CRISPR–Cas immunity using RNA-based anti-CRISPRs

Mechanistic insights into DNA binding and cleavage by a compact type I-F CRISPR-Cas system in bacteriophage

Molecular mechanisms of CRISPR-mediated microbial immunity

Crosstalk between three CRISPR-Cas types enables primed type VI-A adaptation in Listeria seeligeri

A bacteriophage nucleus-like compartment shields DNA from CRISPR nucleases

Type I CRISPR-Cas targets endogenous genes and regulates virulence to evade mammalian host immunity

A functional type II-A CRISPR–Cas system from Listeria enables efficient genome editing of large non-integrating bacteriophage

Cas1 mediates the interference stage in a phage-encoded CRISPR–Cas system

A naturally DNase-free CRISPR-Cas12c enzyme silences gene expression

Cas9–crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria

Cas1 mediates the interference stage in a phage-encoded CRISPR-Cas system

A type III-A CRISPR–Cas system mediates co-transcriptional DNA cleavage at the transcriptional bubbles in close proximity to active effectors